Biogen (BIIB) stock Forecast for 2021 – 2025

Biogen (BIIB) stock Forecast for 2022 – 2026

Last update: 05-24-2022, 5:55

Sector: Healthcare

The share price of Biogen Inc. (BIIB) now

What analysts predict:: $242

52-week high/low: $468.55 / $187.16

50/200 Day Moving Average: $206.8 / $251.16

This figure corresponds to the average price over the previous 50/200 days. For Biogen stocks, the 50-day moving average is the resistance level today.

For Biogen stocks, the 200-day moving average is the resistance level today.

Are you interested in Biogen Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Biogen stock price in 2022, 2023, 2024, 2025, 2026. How much will one Biogen share be worth in 2022 - 2026?

When should I take profit in Biogen stock? When should I record a loss on Biogen stock? What are analysts' forecasts for Biogen stock? What is the future of Biogen stock?

We forecast Biogen stock performance using neural networks based on historical data on Biogen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Biogen stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Biogen shares. This happens once a day.




Historical and forecast chart of Biogen stock

The chart below shows the historical price of Biogen stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Biogen stock price can be found in the table below.

Long-term forecasts by years.

Biogen daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 201.51 199.33 203.68 2.18
May 27 200.66 198.13 202.89 2.40
May 28 196.87 194.39 200.35 3.07
May 29 195.27 193.40 196.86 1.79
May 30 195.22 191.76 199.61 4.09
May 31 195.57 192.22 199.50 3.78
Jun 01 192.63 189.11 194.25 2.72
Jun 02 192.86 189.05 194.60 2.94
Jun 03 195.76 193.06 198.69 2.92
Jun 04 194.47 190.85 197.79 3.64
Jun 05 191.96 190.17 196.33 3.24
Jun 06 197.66 194.69 202.16 3.84
Jun 07 199.79 198.29 204.53 3.14
Jun 08 196.92 193.78 200.64 3.54
Jun 09 194.73 192.92 198.29 2.79
Jun 10 197.24 192.74 199.85 3.68
Jun 11 194.99 193.24 199.44 3.21
Jun 12 194.58 190.09 197.74 4.02
Jun 13 192.83 188.78 196.59 4.14
Jun 14 190.63 186.06 192.41 3.41
Jun 15 192.12 189.01 196.27 3.84
Jun 16 193.39 189.68 197.22 3.98
Jun 17 197.39 195.97 200.06 2.09
Jun 18 202.66 199.99 203.88 1.95
Jun 19 201.45 199.88 203.02 1.57
Jun 20 202.11 200.41 206.84 3.21
Jun 21 200.78 196.74 202.83 3.09
Jun 22 199.87 196.58 201.13 2.32
Jun 23 197.42 193.21 199.37 3.19
Jun 24 192.50 188.98 195.62 3.51

Biogen Daily Price Targets


Biogen Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $201.51. Positive dynamics for Biogen shares will prevail with possible volatility of 2.137%.

Pessimistic target level: 199.33

Optimistic target level: 203.68


Biogen Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $200.66. Negative dynamics for Biogen shares will prevail with possible volatility of 2.344%.

Pessimistic target level: 198.13

Optimistic target level: 202.89


Biogen Stock Forecast 05-28-2022.

Forecast target price for 05-28-2022: $196.87. Negative dynamics for Biogen shares will prevail with possible volatility of 2.977%.

Pessimistic target level: 194.39

Optimistic target level: 200.35


Biogen Stock Forecast 05-29-2022.

Forecast target price for 05-29-2022: $195.27. Negative dynamics for Biogen shares will prevail with possible volatility of 1.756%.

Pessimistic target level: 193.40

Optimistic target level: 196.86


Biogen Stock Forecast 05-30-2022.

Forecast target price for 05-30-2022: $195.22. Negative dynamics for Biogen shares will prevail with possible volatility of 3.931%.

Pessimistic target level: 191.76

Optimistic target level: 199.61


Biogen Stock Forecast 05-31-2022.

Forecast target price for 05-31-2022: $195.57. Positive dynamics for Biogen shares will prevail with possible volatility of 3.647%.

Pessimistic target level: 192.22

Optimistic target level: 199.50


BIIB (BIIB) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 212.91 204.19 219.62 7.02
Jul. 221.86 208.81 239.79 12.92
Aug. 228.38 219.03 239.41 8.51
Sep. 236.77 223.10 246.47 9.48
Oct. 222.10 207.64 233.30 11.00
Nov. 215.34 201.77 221.67 8.98
Dec. 204.71 195.26 210.73 7.34

Biogen forecast for this year


Biogen Stock Prediction for Jun 2022

An uptrend is forecast for this month with an optimal target price of $212.913. Pessimistic: $204.19. Optimistic: $219.62


Biogen Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $221.855. Pessimistic: $208.81. Optimistic: $239.79


Biogen Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $228.378. Pessimistic: $219.03. Optimistic: $239.41


Biogen Stock Prediction for Sep 2022

An uptrend is forecast for this month with an optimal target price of $236.771. Pessimistic: $223.10. Optimistic: $246.47


Biogen Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $222.103. Pessimistic: $207.64. Optimistic: $233.30


Biogen Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $215.34. Pessimistic: $201.77. Optimistic: $221.67


Biogen Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $204.713. Pessimistic: $195.26. Optimistic: $210.73




Biogen (BIIB) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 200.20 190.11 210.08 9.51
Feb 201.88 191.49 206.33 7.19
Mar 223.08 209.02 238.07 12.20
Apr 218.39 203.95 231.24 11.80
May 196.38 190.81 212.67 10.28
Jun 210.81 197.98 217.01 8.77
Jul 225.64 208.59 237.02 12.00
Aug 235.60 224.46 253.65 11.51
Sep 259.84 250.29 273.21 8.39
Oct 273.21 252.55 283.25 10.84
Nov 300.17 276.22 319.08 13.43
Dec 323.81 302.73 335.71 9.82

Biogen (BIIB) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 291.51 280.80 316.00 11.14
Feb 288.45 278.15 310.56 10.44
Mar 276.03 260.09 295.45 11.97
Apr 265.60 253.61 285.12 11.05
May 284.00 267.01 291.76 8.48
Jun 288.78 270.28 302.72 10.72
Jul 318.19 296.80 334.89 11.37
Aug 322.20 314.08 337.76 7.01
Sep 329.30 304.41 351.78 13.47
Oct 297.49 275.00 306.86 10.38
Nov 284.06 273.62 297.48 8.02
Dec 261.99 251.81 280.69 10.29



Biogen (BIIB) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 253.46 235.10 273.15 13.93
Feb 252.13 244.45 268.54 8.97
Mar 265.37 253.11 274.84 7.91
Apr 258.40 241.85 267.08 9.45
May 255.69 247.90 267.50 7.33
Jun 274.75 251.96 289.75 13.04
Jul 280.52 264.91 288.47 8.17
Aug 274.92 264.82 284.74 7.00
Sep 250.38 233.82 261.69 10.65
Oct 249.07 243.58 261.62 6.90
Nov 260.84 241.94 272.34 11.16
Dec 256.18 243.81 263.71 7.55

Biogen (BIIB) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 273.40 259.04 286.03 9.43
Feb 284.88 276.21 295.05 6.39
Mar 284.58 260.98 300.12 13.04
Apr 303.41 290.03 310.42 6.57
May 299.27 276.01 314.03 12.11
Jun 306.49 298.45 319.04 6.46
Jul 314.86 303.62 337.67 10.08
Aug 314.86 297.01 321.47 7.61
Sep 301.64 293.08 316.52 7.40
Oct 296.88 282.86 304.37 7.07
Nov 296.57 277.89 308.72 9.99
Dec 279.45 268.00 292.65 8.42

Biogen information and performance

Biogen is an international biotechnology company that discovers, develops and provides drugs for the treatment of multiple sclerosis (MS) and other hematological, neurodegenerative, autoimmune and other diseases to patients around the world. Biogen is at the forefront of new drug research for neurological diseases and rare genetic diseases.

The company was founded in Geneva (Switzerland) in 1978 by several renowned and forward-thinking biologists. Later one of the founders, Ph.D. Walter Gilbert, received the Nobel Prize in Chemistry for the DNA sequencing method. And in 1993, another founder, Phillip Sharp, received the Nobel Prize in Physiology or Medicine for discovering and showing that the genes of higher organisms have a “discontinuous” structure.

Official site of the company

Biogen Address

225 BINNEY STREET, CAMBRIDGE, MA, US

Market Capitalization: 29 053 149 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 3 923 400 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 19.07

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 8.12

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 10.4

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.075

Quarterly Revenue Growth YOY: -0.042

Trailing PE: 19.07

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 11.93

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 2.941

Enterprise Value (EV) /Revenue

EV To EBITDA: 11.65

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 146452000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.